Decreasing the circulating levels of these auto-antibodies could therefore be beneficial (271, 272), and as such, the blockade of FcRn has been predicted to alleviate IgG-mediated autoimmune diseases (21, 268, 273, 274). The gene discussed is FCGRT; the disease is autoimmune disease.